Oxford BioDynamics (LON:OBD) Shares Pass Above Fifty Day Moving Average – Time to Sell?

Oxford BioDynamics Plc (LON:OBD)’s stock price passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of GBX 0.14 and traded as high as GBX 0.15. Oxford BioDynamics shares last traded at GBX 0.12, with a volume of 69,249,742 shares trading hands.

Oxford BioDynamics Stock Performance

The company has a debt-to-equity ratio of 131.61, a current ratio of 2.01 and a quick ratio of 2.80. The company’s 50-day moving average price is GBX 0.14 and its two-hundred day moving average price is GBX 0.20. The company has a market capitalization of £5.19 million, a price-to-earnings ratio of -0.60 and a beta of 0.42.

Oxford BioDynamics (LON:OBD) last announced its earnings results on Tuesday, June 30th. The biotechnology company reported GBX (0.10) earnings per share for the quarter. Oxford BioDynamics had a negative return on equity of 451.74% and a negative net margin of 825.61%.

About Oxford BioDynamics

Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.

Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.

In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.